Mulligan动态关节松动术治疗卒中后肩痛的疗效观察

注册号:

Registration number:

ChiCTR2000039522 

最近更新日期:

Date of Last Refreshed on:

2021-02-01 00:05:09 

注册时间:

Date of Registration:

2020-10-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

Mulligan动态关节松动术治疗卒中后肩痛的疗效观察

Public title:

Efficacy of Mulligan's mobilization with movement techniques on hemiplegic shoulder pain

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Mulligan动态关节松动术治疗卒中后肩痛的疗效观察

Scientific title:

Efficacy of Mulligan's mobilization with movement techniques on hemiplegic shoulder pain

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

裴子文 

研究负责人:

裴子文 

Applicant:

Pei Ziwen 

Study leader:

Pei Ziwen 

申请注册联系人电话:

Applicant telephone:

+86 13296666644

研究负责人电话:

Study leader's
telephone:

+86 13296666644

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

165592510@qq.com

研究负责人电子邮件:

Study leader's E-mail:

165592510@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北省武汉市硚口区中山大道225号

研究负责人通讯地址:

湖北省武汉市硚口区中山大道225号

Applicant address:

225 Zhongshan Road, Qiaokou District, Wuhan, Hubei, China

Study leader's address:

225 Zhongshan Road, Qiaokou District, Wuhan, Hubei, China

申请注册联系人邮政编码:

Applicant postcode:

430000

研究负责人邮政编码:

Study leader's postcode:

430000

申请人所在单位:

武汉市第一医院

Applicant's institution:

Wuhan NO.1 Hospital

研究负责人所在单位:

武汉市第一医院

Affiliation of the Leader:

Wuhan NO.1 Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

W202007-3

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

武汉市第一医院伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Wuhan No.1 Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-09 00:00:00

伦理委员会联系人:

马艳

Contact Name of the ethic committee:

Ma Yan

伦理委员会联系地址:

湖北省武汉市硚口区中山大道225号

Contact Address of the ethic committee:

225 Zhongshan Road, Qiaokou District, Wuhan, Hubei, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

武汉市第一医院

Primary sponsor:

Wuhan NO.1 Hospital

研究实施负责(组长)单位地址:

湖北省武汉市硚口区中山大道225号

Primary sponsor's address:

225 Zhongshan Road, Qiaokou District, Wuhan, Hubei, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北

市(区县):

武汉

Country:

China

Province:

Hubei

City:

Wuhan

单位(医院):

武汉市第一医院

具体地址:

硚口区中山大道225号

Institution
hospital:

Wuhan NO.1 Hospital

Address:

225 Zhongshan Road, Qiaokou District

经费或物资来源:

武汉市第一医院康复医学科科研经费

Source(s) of funding:

Department of Rehabilitation of Wuhan NO.1 Hospital Research Funds

研究疾病:

脑卒中  

Target disease:

stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探讨Mulligan动态关节松动术治疗脑卒中后肩痛患者的临床效果。  

Objectives of Study:

To explore of the effectiveness of Mulligans mobilization with movement (MWM) techniques on hemiplegic shoulder pain(HSP).

药物成份或治疗方案详述:

将60例卒中后肩痛患者按照随机数字表法分为观察组和对照组,两组患者均进行常规康复治疗,包括:常规康复治疗内容包括:①运动治疗;②作业治疗;③物理因子治疗及中医传统治疗。观察组额外进行Mulligan动态关节松动术治疗,按照 Mulligan 手法指南进行治疗,包括:①肩关节后外侧动态关节松动术;②肩带动态关节松动术;③肩关节内/外旋动态关节松动术;以上所有治疗1次/天,每周6 d,持续4周。 

Description for medicine or protocol of treatment in detail:

60 patients with HSP were divided into experiment group and control group according to the random number table method. Both groups received conventional rehabilitation treatment, including therapeutic exercise, occupational therapy, physical agent therapy, and traditional Chinese medicine treatment. In the experiment group, additional treatment with dynamic joint loosening was performed in accordance with the Mulligan manual, including Shoulder postero-lateral glide; MWM?to?shoulder?girdle; MWM to internal and external movement of the shoulder; All the above treatments were administered once a day for 6 days per week for 4 weeks. 

纳入标准:

Inclusion criteria

排除标准:

(1)MRI检查表现有肩袖或肱二头肌肌腱重度撕裂,需要手术者。
(2)卒中前患侧有慢性肩痛病史或曾进行过肩部手术;
(3)卒中后有复杂性区域疼痛综合征;
(4)患侧存在严重感觉障碍者;
(5)患侧上肢肌张力过高(改良Ashworth分级Ⅱ级及以上)。

Exclusion criteria:

(1) MRI examination showed severe rotator cuff or biceps tendon tear of the patients needing surgery.
(2) Had a history of chronic shoulder pain or had undergone shoulder surgery before stroke.
(3) Had complex regional pain syndrome after stroke.
(4) Had severe sensory dysfunciton on the affected side.
(5) Spasticity of 2 or more points as determined by the Modified Ashworth Scale (MAS).

研究实施时间:

Study execute time:

From 2020-11-01 00:00:00 To 2021-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-11-01 00:00:00 To 2020-12-01 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

30

Group:

control group

Sample size:

干预措施:

常规康复治疗

干预措施代码:

Intervention:

conventional rehabilitation treatments (CRT)

Intervention code:

组别:

观察组

样本量:

30

Group:

experimental group

Sample size:

干预措施:

常规康复治疗+动态关节松动术

干预措施代码:

Intervention:

CRT+MWM

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

武汉市第一医院 

单位级别:

三甲 

Institution
hospital:

Wuhan NO.1 Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

疼痛评分

指标类型:

主要指标

Outcome:

visual analogue scale (VAS)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

关节活动度

指标类型:

次要指标

Outcome:

range of motion (ROM)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Constant-Murley肩关节功能障碍评分

指标类型:

次要指标

Outcome:

Chinese version of the Constant-Murley questionnaire for shoulder pain and disability (CMS)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Fugl-Meyer上肢运动功能评分

指标类型:

次要指标

Outcome:

Fugl-Meyer assessment scale of upper extremity (FMA-UE)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由朱元霄通过SPSS22进行产生随机序列。

Randomization Procedure (please state who generates the random number sequence and by what method):

Zhu Yuanxiao,through SPSS 22.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

对受试者、数据收集及统计施盲

Blinding:

Blind method for subjects, data collectors and statisticians.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

百度云盘 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

https://pan.baidu.com/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-10-30 19:53:40